Clinical and Translational Science Award (UM1 Clinical Trial Optional)
ID: 356316Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/356316

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-24-272.html
Timeline
    Description

    The National Institutes of Health (NIH) has announced a funding opportunity for the Clinical and Translational Science Award (CTSA) Program, aimed at enhancing clinical and translational research through collaborative partnerships. This initiative invites applications for hubs that will focus on improving the efficiency of clinical translation, addressing health disparities, and fostering innovative research methodologies, with a particular emphasis on community engagement and workforce development. Successful applicants, which may include higher education institutions and nonprofit organizations, are expected to outline strategic management and demonstrate strong leadership, with projects capped at seven years and a submission deadline of September 28, 2027. For further details, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the funding opportunity page at https://grants.nih.gov/grants/guide/pa-files/PAR-24-272.html.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-24-272.html
    The Department of Health and Human Services, through the National Institutes of Health (NIH), has announced a funding opportunity for the Clinical and Translational Science Award (CTSA) Program, aimed at accelerating clinical and translational research. The CTSA Program encourages applications for hubs that foster collaborative partnerships to streamline the development and dissemination of healthcare innovations across diverse communities. Key focus areas include enhancing research efficiency, addressing health disparities, and nurturing the capacity of clinical research professionals. The NOFO invites multiple types of applicants, notably higher education institutions and nonprofit organizations, with a project budget based on preceding NIH funding levels. Successful hub applications must outline strategic management, workforce development, community engagement, and innovative research methodologies with defined goals. Hubs are expected to not only conduct but also disseminate findings that contribute broadly to the translational science landscape. Applications are to be submitted by specific dates in 2025, with projects capped at seven years. This announcement reflects the NIH's commitment to improving healthcare outcomes through science, enhancing resource sharing and collaborative efforts within the CTSA consortium and beyond. Essential characteristics of successful hubs include strong leadership, institutional support, and a commitment to continuous quality improvement within the clinical research framework.
    Similar Opportunities
    Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science for UM1 CTSA Hub Awards (RC2 Clinical Trials Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Limited Competition Funding Opportunity titled "High Impact Specialized Innovation Programs in Clinical and Translational Science for UM1 CTSA Hub Awards." This initiative aims to support the development of unique capabilities and resources to address critical gaps in clinical and translational science within awarded UM1 Clinical and Translational Science Awards (CTSA) Program Hubs. The funding opportunity, numbered PAR-25-156, allows for project budgets of up to $500,000 per year over a project period of up to five years, with applications involving clinical trials being optional. Interested applicants, primarily from public and state-controlled institutions of higher education, must submit detailed integration plans, milestones, and sustainability evaluations by the closing date of September 28, 2026. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science for UM1 CTSA Hub Awards (RC2 Clinical Trials Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science for UM1 CTSA Hub Awards." This initiative aims to support the development and demonstration of innovative resources and capabilities within Clinical and Translational Science Awards (CTSA) Program hubs, specifically targeting critical gaps and roadblocks in clinical research. Successful applicants, who must be active UM1 CTSA award recipients, will propose projects lasting up to five years with an annual budget cap of $500,000, emphasizing collaboration and innovation in health research. Interested parties should note that the application deadline is September 14, 2026, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Limited Competition funding opportunity titled the Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3), aimed at enhancing translational research through collaborative efforts among multiple medical research institutions. This initiative seeks to support the development, implementation, and dissemination of innovative solutions that address urgent public health needs and promote health equity, requiring applicants to include at least three eligible organizations to foster interdisciplinary partnerships. Eligible projects can receive funding of up to $650,000 annually for a total duration of up to five years, with applications due by October 19, 2027. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the official announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-25-296.html.
    Notice of Intent to Publish a Notice of Funding Opportunity for the Re-Issue of PAR-21-293 - Clinical and Translational Science Award (UM1 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to reissue a Notice of Funding Opportunity (NOFO) for the Clinical and Translational Science Award (CTSA) Program, aimed at establishing hubs that will contribute to a national consortium focused on accelerating the delivery of treatments to patients through advancements in clinical and translational science. This initiative is designed to foster meaningful collaborations and responsive projects among eligible applicants, which include various organizations and institutions. The anticipated NOFO is expected to be published in Summer 2024, with applications due by January 2025, and the estimated award date is set for December 16, 2025. Interested parties should prepare for the upcoming application process as no cost-sharing or matching is required for this cooperative agreement funding opportunity.
    Notice of Intent to Re-issue PAR-22-167 - Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to re-issue the Notice of Funding Opportunity Announcement (PAR-22-167) for the Clinical and Translational Science Award (CTSA) Program, specifically the Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional). This funding opportunity aims to foster meaningful collaborations and innovative projects in clinical and translational science, with no cost-sharing or matching requirements for eligible applicants, which include for-profit organizations. The estimated total program funding is $5 million, with an award ceiling of $650,000, and the NOFO is expected to be published in Fall 2024, with applications due in Winter 2025. Interested parties should prepare for the anticipated timeline, as the estimated project start date is December 1, 2025, and further details can be found on the CCIA webpage.
    Limited Competition: Mentored Research Career Development Program Award in Clinical and Translational Science Awards (CTSA) Program (K12 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a limited competition grant opportunity for the Mentored Research Career Development Program Award under the Clinical and Translational Science Awards (CTSA) Program. This initiative aims to develop innovative career advancement programs for later-stage postdoctoral fellows and junior faculty who are committed to independent clinical and translational science research careers, facilitating their transition into leadership roles through structured mentorship and research experiences. The program is designed to enhance the clinical and translational science workforce, addressing national biomedical research needs, and encourages diversity among scholars. Eligible institutions may submit a single K12 application alongside a UM1 application, with a funding period of up to five years. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov, with the application deadline set for September 28, 2027.
    Limited Competition: Ruth L. Kirschstein National Research Service Award (NRSA) Predoctoral Research Training Grant for the Clinical and Translational Science Awards (CTSA) Program (T32 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Ruth L. Kirschstein National Research Service Award (NRSA) Predoctoral Research Training Grant under the Clinical and Translational Science Awards (CTSA) Program. This grant aims to support eligible institutions in developing and disseminating training and career support programs for individuals pursuing a PhD or equivalent research health professional degree, with a focus on fostering a diverse pool of clinical and translational scientists equipped to address pressing health needs. The program is critical for advancing research in diagnostics, therapeutics, and clinical interventions, ultimately enhancing health outcomes. Interested institutions must note that the application deadline is September 28, 2027, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries. More details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-25-194.html.
    Limited Competition: Ruth L. Kirschstein National Research Service Award (NRSA) Postdoctoral Research Training Grant for the Clinical and Translational Science Awards (CTSA) Program (T32 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Ruth L. Kirschstein National Research Service Award (NRSA) Postdoctoral Research Training Grant under the Clinical and Translational Science Awards (CTSA) Program. This grant aims to support eligible institutions in developing and disseminating training programs that enhance postdoctoral research training for individuals holding doctoral degrees in various health-related fields, thereby fostering a diverse pool of clinical and translational scientists. The initiative is crucial for advancing research that addresses significant health needs and supports the development of diagnostics, therapeutics, and clinical interventions. Interested institutions must note that the application deadline is September 28, 2027, and can find more information at the provided NIH grants link or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through its National Center for Advancing Translational Sciences (NCATS), has announced a funding opportunity for the Limited Competition Small Grant Program (R03), aimed at supporting Clinical and Translational Science Award (CTSA) Program KL2/K12 scholars and diversity supplement recipients. This program is designed to facilitate the transition of these scholars to independent research careers by funding small, self-contained research projects that can be conducted quickly and with limited resources, ultimately addressing inefficiencies in translational science. Grants of up to $50,000 per year are available for projects lasting up to two years, with a submission deadline of January 17, 2025, and an anticipated award cycle beginning in February 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Notice of Intent to Publish a Notice of Funding Opportunity for the Re-issue of PAR-21-339 - Limited Competition: NCATS Clinical and Translational Science Award (CTSA) Program Research Education Grants Programs (R25 - Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to reissue a Notice of Funding Opportunity (NOFO) for the Limited Competition: NCATS Clinical and Translational Science Award (CTSA) Program Research Education Grants Programs (R25), with a focus on educational activities that enhance research experiences in clinical and translational science. This initiative aims to support recipients of Clinical and Translational Science Awards (CTSA) by providing exposure to the scientific and operational principles of the translational process, covering areas such as pre-clinical research, clinical research, clinical implementation, and public health. The anticipated funding amount for this grant is up to $100,000, with the NOFO expected to be published in Summer 2024 and applications due by January 27, 2025. For further details, potential applicants are encouraged to prepare their proposals in advance of the expected award date on December 16, 2025.